Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Cancer Metastatic 3 Neoplasm Metastasis 2 Uveal Melanoma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neurofibromatosis 2 1 Neoplasms 1 Macular Degeneration 1 Lung Neoplasms 1 Colorectal Neoplasms 1 Carcinoma 1

Interventions

Gemcitabine 74 Fluorouracil 31 Oxaliplatin 21 Leucovorin 21 130-nm albumin-bound paclitaxel 17 Capecitabine 14 Irinotecan 12 Albumin-Bound Paclitaxel 10 irinotecan sucrosofate 8 Radiotherapy 6 Taxes 5 Erlotinib Hydrochloride 5 folfirinox 4 rubitecan 3 Surgical Procedures, Operative 3 Specimen Handling 3 Pancreaticojejunostomy 3 Neoadjuvant Therapy 3 Drug Therapy 3 Cisplatin 3 Chemotherapy, Adjuvant 3 ruxolitinib 2 masitinib 2 dehydroftorafur 2 Saline Solution 2 S 1 (combination) 2 Paclitaxel 2 GV1001 peptide 2 Fentanyl 2 Bevacizumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Pancreatic Neoplasms × aflibercept × Clear all

NCT00574275 2016-06-07

VANILLA

Sanofi

Phase 3 Terminated

546 enrolled 14 charts

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡